Category Archives: Byetta Cancer

Featured Stories

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Image Source: saidaonline.com

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

Whistleblower Wins Retaliation - Canaveral National Seashore

Whistleblower Wins Retaliation Lawsuit

A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports.

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Study: Type 2 Diabetes Drugs May Lead to Pancreatic Damage

A recent study found that Type 2 diabetics taking drugs such as Januvia and Byetta, might be at increased risk for pancreatic damage, including pancreatic cell growth that could lead to cancer. The study, out of the University of California, … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Some Type 2 Diabetes Drugs Associated with Pancreatitis, Pancreatic Cancer

Some Type 2 diabetes drugs are being associated with potential increased risks for pancreatitis and pancreatic cancer. The drugs, known as incretin mimetic drugs include drugs such as  Byetta and Bydureon (exenatide); Victoza (liraglutide); Januvia, Janumet, Janumet XR, and Juvisync … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

FDA Evaluating Cancer Risks in Type 2 Diabetes Drugs

In a just-released U.S. Food and Drug Administration (FDA) Drug Safety Communication, the agency said it is investigating reports of possible increased risk of pancreatitis and pre-cancerous findings in some Type 2 diabetes drugs. Incretin mimetic drugs imitate the body’s … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

JAMA Study: Januvia, Byetta Double Risks for Pancreatitis

Prior research revealed that Januvia (sitagliptin) and Byetta (exenatide), prescribed for the treatment of Type 2 diabetes, have been associated with reports of increased risks for pancreatic and thyroid cancers. Now, a new study finds that the drugs may double … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Januvia, Byetta Linked to Adverse Health Events

Januvia (sitagliptin) and Byetta (exenatide), prescribed for the treatment of Type 2 diabetes, have been associated with reports of increased risks for pancreatic and thyroid cancers. Researchers at the University of California, Los Angeles looked at the both Januvia and … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Amylin Hid Byetta Study Showing Association with Heart Side Effects, FDA Says

Amylin Pharmaceuticals, the maker of Byetta, is coming under fire for allegedly hiding a study that revealed serious heart risks associated with the type 2 diabetes medication.  According to a report from TheStreet.com, the U.S. Food & Drug Administration (FDA) … Continue reading

Posted in Byetta Cancer, Pharmaceuticals | Tagged |

Pancreas Worries Have Some Docs Backing Away From Byetta, Januvia

A new study indicates that some doctors are becoming wary of Januvia (sitagliptin) and Byetta (exenatide), after research linked the type 2 diabetes drugs to an increased risk of pancreatitis and pancreatic cancer. The survey, conducted by DTW Research, found … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Victoza Raises Thyroid Tumor, Pancreatitis Fears

The maker of < "http://www.yourlawyer.com/practice_areas/defective_drugs">Victoza (liraglutide) is reminding doctors of some serious side effects that may be associated with the Type II Diabetes drug – thyroid C-cell tumors and acute pancreatitis. Novo Nordisk decided to issue a “Dear Healthcare Provider” … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Victoza, Similar Diabetes Drugs Raise Safety Concerns

< "http://www.yourlawyer.com/practice_areas/defective_drugs">Victoza, a Type 2 Diabetes drug approved just last year, is raising concerns about pancreatitis. According to the Institute for Safe Medication Practices’ (ISMP) latest “QuarterWatch” report, Victoza has been associated with a growing number of pancreatitis cases since … Continue reading

Posted in Byetta Cancer |

Amylin Wins Temporary Restraining Order in Byetta Spat

Amylin Pharmaceuticals has scored a victory in its quest to prevent Eli Lilly from using its Byetta sales force from marketing a competing drug. < "http://www.yourlawyer.com/topics/overview/Byetta-Side-Effects-Pancreatic-Liver-Thyroid-Cancer-Lawsuit">Byetta, which is treats Type II diabetes, is marketed jointly by Eli Lilly and Amylin. … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.